Neonatal Abstinence Syndrome

Slides:



Advertisements
Similar presentations
Infants of addicted mothers Vandana Nayal, MD Edited 6/2005.
Advertisements

Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric Pharmacy Resident Peyton Manning Children’s Hospital St.
Neonatal Abstinence Syndrome: A Family Centered Approach to Care Kelly Outlaw, M.S., CCLS.
Chapter3 Problems of the neonate and young infant - Neonatal resuscitation.
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
Opioid Dependence During Pregnancy Michelle Lofwall, M.D. University of Kentucky 1 © AMSP 2009.
C ARING FOR INFANTS WITH SHORT - AND LONG - TERM EFFECTS OF IN - UTERO OPIOID EXPOSURE Bonny Whalen, MD Medical Director / Newborn Pediatrician CHaD/DHMC.
Neonatal Abstinence Syndrome. Risks for developing NAS Opioids – Opiate derivatives, interact with mu-opioid receptor Abstinence syndrome (withdrawal)
SUBSTANCE ABUSE The Drug-Exposed Infant
OPIOIDS Dr. Hisham Zein Alabdin. Plant origin  It is the dried extract of the poppy plant: Popover somniferum.  Raw opium typically is composed of at.
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Kelly Geraghty, Tracy James, Kristen Lintjer,
Neonatal Abstinence Syndrome (NAS)
V.Sideri, C.Vliora, A.Daskalaki, P.Mexi-Bourna, K.Kleanthous, M.Soulioti, G. Kyrkou, N.Bournas, V.Papaevangelou 3 rd Pediatric Clinic of the University.
Childhood Development Affected by Prenatal Drug Abuse Milene Francis Psychology 1100 April, 2014.
Psychoactive Drugs Drugs that affect the brain, changing mood or behavior % of adults in North America use some kind of drug on a daily basis. The.
Education Guide for Parents and Caregivers. Neonatal Abstinence Syndrome (NAS) NAS may present in a baby who is exposed to medication taken by the mother.
Chapter 8: Chronic Alcohol Third leading preventable cause of death in the US.
Chapter 13 Opioids.
FDA Advisory committee: Neonatal Opioid Withdrawal Syndrome
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Opioid (Narcotic) Analgesics and Antagonists.
A healthy neonate was born to a GBS + mother that was given Amp only 3 hours prior to delivery. Since you know that was not effective treatment, you decide.
Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.
© 2011 The McGraw-Hill Companies, Inc. Instructor name Class Title, Term/Semester, Year Institution Introductory Psychology Concepts Altered Consciousness:
SUBSTANCE ABUSE & NEWBORNS
Sh. Pourarian Neonatologist Epidemiology A survey in 1985 by the national institute of drug Abuse (NIDA) showed. 23 million people in U.S. used illicit.
©2013 Children's Mercy. All Rights Reserved. 09/13 The Drug Exposed Neonate; Now What? Neonatal Abstinence Syndrome (NAS) Betsy Knappen APRN, BSN, Jodi.
MATERNAL & NEONATAL WITHDRAWAL SYNDROME BY: Dr. F.Goudarzi Clinical Toxicologist SUMS.
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome Lauritz Meyer, MD September 11, 2015 SDPA Conference.
Initial Neonatal Work-up First urine-will only detect very recent substance use First meconium-will detect substances used after 20 weeks gestation StandardizedNAS.
Medicine and Illegal Drugs
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
M ANAGEMENT OF THE O PIATE -E XPOSED N EWBORN AND I MPLICATIONS FOR B REASTFEEDING Bonny Whalen, MD - Medical Director, Newborn Nursery at CHaD/Dartmouth-Hitchcock.
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Treating Pregnant Opioid Dependent Women: Examining Buprenorphine and Methadone Hendrée E. Jones, Ph.D. Associate Professor Department of Psychiatry and.
Improving Care for Opioid Exposed Newborns September 11, 2006 NNEPQIN Dartmouth Hitchcock Medical Center Anne Johnston, MD Associate Professor of Pediatrics.
Heroin Addiction. What is heroin? Heroin is an opioid, derived from the opium poppy الخشخاش Heroin is an opioid, derived from the opium poppy الخشخاش.
مردم دو دسته اند : دسته اي برادر ديني تو و دسته ديگر همانند تو در آفرينش. اگر گناهي از آنان سر مي زند يا علت هايي بر آنان عارض مي شود، يا خواسته و ناخواسته.
Substance abuse. Substance abuse, dependence, withdrawal, tolerance, and demographics Substance abuse, dependence, withdrawal, tolerance, and demographics.
By: Nicole Stevens  A syndrome of drug withdrawal with non- specific signs and symptoms that may occur in babies following in-utero drug exposure. 
The Problem of Neonatal Abstinence Syndrome (NAS) Opiates and Pregnancy.
Analgesics and Antipyretics
Sean Maloney, M.A.,LMHC. Characteristics of Drug Exposed Infants Factors Influencing Effects of Prenatal Exposure Interventions.
Anne Merewood PhD MPH IBCLC Associate Professor of Pediatrics, Boston University School of Medicine Consultant to the Rocky Mountain Tribal Leaders Council.
Abusing Drugs During Pregnancy is Child Abuse Hannah Magyar CP English 12 Mrs. Mahoney May 5, 2015.
Neonatal Abstinence Syndrome
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
Opioid Use Disorder in Pregnancy Tara Benjamin, MD, MS Assistant Clinical Professor Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology.
Care of the Neonate with Prenatal Opioid Exposure – Advanced Practice
Timby/Smith: Introductory Medical-Surgical Nursing, 11/e
مردم دو دسته اند: دسته اي برادر ديني تو و دسته ديگر همانند تو در آفرينش .اگر گناهي از آنان سر مي زند يا علت هايي بر آنان عارض مي شود، يا خواسته و ناخواسته.
Chapter 3 Problems of the neonate and young infant - Birth Asphyxia
High Risk neonatal nursing
Medication Assisted Treatment and Pregnancy
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome
Presented by J. Arzaga, MSN, RN
Neonatal Nursing Care Neonatal Complications
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
WisPQC Standardized Protocol Webinar for NAS/NOWS Initiative
Opioids Objectives Understand opioids overdose pathophysiology.
Low birth weight By : - dr . sanjeev.
Seyed Mostafa Mirakbari MD
Chapter 3 Problems of the neonate and young infant - Birth Asphyxia
NEONATAL ABSTINENCE SYNDROME
Mommies Program – Outpatient Treatment NAS Residential Treatment
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Presentation transcript:

Neonatal Abstinence Syndrome Karen Estrella-Ramadan 06/25/2012

Acute use of heroin and other opioids stimulate opiate receptors in the brain which may result in symptoms including euphoria, resp depression, analgesia and nausea. Chronic use of opioids s associated with tolerance, which later leads to dependence, whereby the neurochemical balance in the CNS is altered and absence of the drugs leads to withdrawal syndrome

Opioids and pregnancy Repetitive use and withdrawal leads to ftal hypoxia, fetal demise, IUGR, SGA Medication-assisted tx with methadone Long half life With advance pregnancy is metabolized faster and higher doses are required

Neonatal Abstinence Syndrome Timing Heroin: 48-72hrs Methadone: 4 days Screening: Newborn urine: 24-48hrs Amphetamines, barbiturates, benzos, cocaine, marijuana, some opioids-my not include methadone or oxycodone Meconium toxicology First 3-4 days Ampehtamines, opiods, cocaine, marijuana

Clinical Features NEUROLOGICAL: Tremors Irritability Increased wakefulness High-pitched crying Increased muscle tone Hyperactive deep tendon reflexes Exaggerated Moro reflex Seizures Frequent yawning and sneezing GI DYSFUNCTION: Poor feeding Uncoordinated and constant sucking Vomiting Diarrhea Dehydration Poor weight gain AUTONOMIC SIGNS: Increased sweating Nasal stuffiness Fever Mottling Temperature instability

Treatment ~50-70% of infants will require tx At delivery, NO naloxone= seizures SCORING (modified Finnegan) Before feeding

1. Supportive Encourage maternal and paternal involvement Decrease stimulation: no light, no loud sounds, examination Swaddling, soothing, rocking (vertical) Non-nutritive sucking: Pacifier Skin-skin contact: Kangaroo care Skin care: lotion to areas of abrassion Frequent feedings: increase caloric intake (150-250 cal/kg/day) May allow BF if neg Utox in mother, HIV neg

2. Pharmacological Scoring >9 (x3: before and after feeding) or 2 >than 12 Short acting opioid: MORPHINE (0.4 mg/ml) Start with 0.03 mg/kg/day 0.2 mg po q4hrs Scoring: q8-12hrs If still high: increase by 0.16mg/kg/day q3hrs (max 0.8mg/kg/day) Monitor: Over-sedation, decreased arousal, resp depression Wean after 48hrs on scores <6 Decrease 20% of daily dose Continue scoring Wean after 28-72hrs on scores <6, and less freq feedings d/c morphine Once sub therapeutic dose is achieved, observe for 24-28 hrs off morphine If sz: diff dx workup Add phenobarbital if no control of symptoms with max dosing

Discharge Off morphine for 24hrs with score <6 Adequate nutrition No more than 10% wt loss SW clearance f/u with PMD

Other things to consider Screens for: Syphilis Hepatitis B Hepatitis C HIV Tb DV

Differential dx Sepsis Hypoglycemia Hypocalcemia hypomagnesemia Hyperthyroidism Perinatal asphyxia IVH

References http://www.uvm.edu/medicine/vchip/documents/VCHIP_5NEONATAL_GUIDELINES.pdf (University of Vermont) http://nctnc.org/workfiles/NAS.pdf (University of Connecticut) NICU-SBH http://pediatrics.aappublications.org/content/101/6/1079.full